
2021‘s Pharmaceutical Industry Network Group (PING) conference focused on the UK’s COVID-19 response and how it can continue as a leader in science innovation and collaboration, including opportunities through use of health and genomic data.
Paul Gershlick is Chair of PING and Partner and Head of Pharmaceuticals and Life Sciences at VWV Watford.

Published: January 5th 2022 | Updated: